Amedisys (NASDAQ:AMED) issued its earnings results on Tuesday. The health services provider reported $0.56 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.02), Bloomberg Earnings reports. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. During the same period in the prior year, the company posted $0.44 earnings per share.
Shares of Amedisys (NASDAQ AMED) traded up $1.55 during midday trading on Tuesday, hitting $59.43. The company had a trading volume of 536,688 shares, compared to its average volume of 336,628. The stock has a market cap of $1,960.00, a PE ratio of 47.17, a price-to-earnings-growth ratio of 1.17 and a beta of 0.73. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. Amedisys has a 52 week low of $45.60 and a 52 week high of $65.91.
Several research analysts have commented on AMED shares. Robert W. Baird raised their target price on Amedisys from $50.00 to $60.00 and gave the stock a “neutral” rating in a research note on Friday, November 10th. William Blair reaffirmed an “outperform” rating on shares of Amedisys in a report on Tuesday, November 21st. SunTrust Banks reaffirmed a “buy” rating and issued a $70.00 price target on shares of Amedisys in a report on Friday, November 10th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $62.00 price target (up previously from $56.00) on shares of Amedisys in a report on Thursday, November 9th. Finally, Zacks Investment Research raised Amedisys from a “hold” rating to a “buy” rating and set a $62.00 price objective on the stock in a report on Monday, January 22nd. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $60.64.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.